0      0

Breakfast Activity/Non-CE-Accredited Satellite Symposium: Learn more about a CAR T cell therapy for relapsed/refractory multiple myeloma (RRMM) <br> Bristol Myers Squibb </br> <br> <i> Seating available on first-come, first served basis </br></i>

‐ Nov 11, 2023 7:45am

Amani Kitali, MBA, MPH, PMP

You must be logged in and own this session in order to post comments.